Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update
- PMID: 36689694
- PMCID: PMC10022858
- DOI: 10.1200/JCO.22.02224
Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update
Abstract
Purpose: To update a clinical practice guideline (CPG) for the empiric management of fever and neutropenia (FN) in pediatric patients with cancer and hematopoietic cell transplantation recipients.
Methods: The International Pediatric Fever and Neutropenia Guideline Panel reconvened to conduct the second update of this CPG. We updated the previous systematic review to identify new randomized controlled trials (RCTs) evaluating any strategy for the management of FN in pediatric patients. Using the Grading of Recommendations Assessment, Development and Evaluation framework, evidence quality was classified as high, moderate, low, or very low. The panel updated recommendations related to initial management, ongoing management, and empiric antifungal therapy. Changes from the 2017 CPG were articulated, and good practice statements were considered.
Results: We identified 10 new RCTs in addition to the 69 RCTs identified in previous FN CPGs to inform the 2023 FN CPG. Changes from the 2017 CPG included two conditional recommendations regarding (1) discontinuation of empiric antibacterial therapy in clinically well and afebrile patients with low-risk FN if blood cultures remain negative at 48 hours despite no evidence of marrow recovery and (2) pre-emptive antifungal therapy for invasive fungal disease in high-risk patients not receiving antimold prophylaxis. The panel created a good practice statement to initiate FN CPG-consistent empiric antibacterial therapy as soon as possible in clinically unstable febrile patients.
Conclusion: The updated FN CPG incorporates important modifications on the basis of recently published trials. Future work should focus on addressing knowledge gaps, improving CPG implementation, and measuring the impact of CPG-consistent care.
Conflict of interest statement
Guideline for the Management of Fever and Neutropenia in Pediatric Patients with Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
Comment in
-
Fever and neutropenia in pediatric oncology and stem cell transplant patients: an editorial commentary on updated international clinical practice guidelines.Transl Pediatr. 2023 Oct 30;12(10):1908-1912. doi: 10.21037/tp-23-368. Epub 2023 Oct 20. Transl Pediatr. 2023. PMID: 37969121 Free PMC article. No abstract available.
Similar articles
-
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1. J Clin Oncol. 2017. PMID: 28459614
-
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation.J Clin Oncol. 2012 Dec 10;30(35):4427-38. doi: 10.1200/JCO.2012.42.7161. Epub 2012 Sep 17. J Clin Oncol. 2012. PMID: 22987086
-
A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.Pediatr Infect Dis J. 2014 Sep;33(9):e219-25. doi: 10.1097/INF.0000000000000326. Pediatr Infect Dis J. 2014. PMID: 24618935 Free PMC article. Clinical Trial.
-
Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.J Pediatr Hematol Oncol. 2020 Aug;42(6):e445-e451. doi: 10.1097/MPH.0000000000001814. J Pediatr Hematol Oncol. 2020. PMID: 32404688
-
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.Clin Infect Dis. 2020 Jun 24;71(1):226-236. doi: 10.1093/cid/ciz1082. Clin Infect Dis. 2020. PMID: 31676904 Free PMC article.
Cited by
-
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes.Lancet Reg Health West Pac. 2024 Nov 2;53:101226. doi: 10.1016/j.lanwpc.2024.101226. eCollection 2024 Dec. Lancet Reg Health West Pac. 2024. PMID: 39553416 Free PMC article.
-
Protocol for an embedded randomised controlled trial of Early versus Late Stopping of Antibiotics in children with Febrile Neutropenia (ELSA-FN).PLoS One. 2024 Dec 9;19(12):e0311523. doi: 10.1371/journal.pone.0311523. eCollection 2024. PLoS One. 2024. PMID: 39652544 Free PMC article.
-
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.J Clin Oncol. 2024 Mar 1;42(7):832-841. doi: 10.1200/JCO.23.01814. Epub 2023 Dec 7. J Clin Oncol. 2024. PMID: 38060973 Free PMC article.
-
Bacteriuria in Paediatric Oncology Patients: Clinical Features, Distribution and Antimicrobial Susceptibility of Bacterial Pathogens at University Hospital Centre Zagreb, Croatia over a 4-Year Period.Antibiotics (Basel). 2024 Jan 25;13(2):118. doi: 10.3390/antibiotics13020118. Antibiotics (Basel). 2024. PMID: 38391504 Free PMC article.
-
Vital signs continuously monitored by two wearable devices in pediatric oncology patients, NCT04914702.Sci Data. 2025 May 17;12(1):807. doi: 10.1038/s41597-025-05081-x. Sci Data. 2025. PMID: 40382374 Free PMC article.
References
-
- Haeusler GM, Slavin MA, Bryant PA, et al. : Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice. J Paediatr Child Health 54:761-769, 2018 - PubMed
-
- Boragina M, Patel H, Reiter S, et al. : Management of febrile neutropenia in pediatric oncology patients: A Canadian survey. Pediatr Blood Cancer 48:521-526, 2007 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous